Leveraging existing data to contextualize phase II clinical trial findings in oncology

Ann Oncol. 2020 Dec;31(12):1591-1593. doi: 10.1016/j.annonc.2020.09.008. Epub 2020 Sep 22.

Authors

E M Ray¹, L A Carey², K E Reeder-Hayes²

Affiliations

¹ Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, USA. Electronic address: emily_ray@med.unc.edu.
² Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, USA.

PMID: 32976939
DOI: 10.1016/j.annonc.2020.09.008

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Medical Oncology*
Paclitaxel*
Research Design
Trastuzumab
United States
United States Food and Drug Administration

Substances

Trastuzumab
Paclitaxel